Clinical Trials Directory

Trials / Completed

CompletedNCT04953507

Evaluation of T2, T3 Sympathectomy for Postmastectomy Pain Syndrome by Pulse Oximeter

Evaluation of T2, T3 Sympathectomy for Postmastectomy Pain Syndrome by Thermal Radiofrequency Versus Chemical Neurolysis Using Perfusion Index Derived Pulse Oximeter

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
54 (actual)
Sponsor
National Cancer Institute, Egypt · Academic / Other
Sex
Female
Age
18 Years – 70 Years
Healthy volunteers
Not accepted

Summary

The aim of the study is to compare the efficacy of T2, T3 sympathetic block using thermal radiofrequency versus chemical neurolysis in postmastectomy pain syndrome using perfusion index derived from pulse oximetry.

Detailed description

Postmastectomy pain is a chronic pain condition with neuropathic nature. Several drugs and methods are used for its management. This study was designed to compare the efficacy of both thermal radiofrequency and chemical neurolysis in management of postmastectomy pain through using perfusion index derived from pulse oximetry.

Conditions

Interventions

TypeNameDescription
PROCEDUREThermal RadiofrequencyRadiofrequency lesioning at level of T2 and T3 using 80°c for 120 seconds
PROCEDUREChemical Neurolysisinjection of 1.5 ml of the chemical neurolytic agent (phenol in saline 8%) at each level

Timeline

Start date
2021-07-03
Primary completion
2025-02-10
Completion
2025-02-25
First posted
2021-07-08
Last updated
2025-07-18

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT04953507. Inclusion in this directory is not an endorsement.